Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
UBS
Express Scripts
Daiichi Sankyo
Cipla
Chinese Patent Office

Generated: September 17, 2019

DrugPatentWatch Database Preview

Patent: 10,398,685

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,398,685
Title:Methods of treating pancreatic cancer
Abstract: The present disclosure describes methods of treating pancreatic cancer and limiting over-expression of oncogenes, activating tumor suppressor genes or regulating signaling proteins in patients comprising administering compounds and pharmaceutical combinations as described herein.
Inventor(s): Bekker; Petrus (Mountain View, CA), Miao; Shichang (Foster City, CA), Charo; Israel (Mountain View, CA), Schall; Tom (Mountain View, CA)
Assignee: ChemoCentryx, Inc. (Mountain View, CA)
Application Number:16/266,961
Patent Claims:see list of patent claims

Details for Patent 10,398,685

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emd Serono Inc BAVENCIO avelumab INJECTABLE;INJECTION 761049 001 2017-04-25 ➤ Sign Up ChemoCentryx, Inc. (Mountain View, CA) 2036-06-13 RX Orphan search
Astrazeneca Uk Ltd IMFINZI durvalumab INJECTABLE;INJECTION 761069 001 2017-05-01 ➤ Sign Up ChemoCentryx, Inc. (Mountain View, CA) 2036-06-13 RX search
Emd Serono Inc BAVENCIO avelumab INJECTABLE;INTRAVENOUS 761078 001 2017-05-09 ➤ Sign Up ChemoCentryx, Inc. (Mountain View, CA) 2036-06-13 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
McKinsey
US Department of Justice
Argus Health
Medtronic
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.